```html

Psychosis – Comprehensive Medical Guide

Overview

Psychosis is a medical term that describes a loss of contact with reality. People experiencing psychosis may have hallucinations (perceiving things that are not there), delusions (strongly held false beliefs), or disorganized thinking that interferes with daily functioning. Psychotic episodes can occur in the context of several mental health disorders, medical illnesses, substance use, or as an isolated brief psychotic event.

Who it affects

• Onset typically occurs in late adolescence or early adulthood (ages 16‑30), but can appear at any age.
• Both men and women are affected; however, men often experience an earlier onset.
• Worldwide, an estimated 3–5 % of the population will experience a psychotic disorder at some point in their lives <sup>[1]</sup>.

Prevalence

• Schizophrenia, the most well‑known psychotic disorder, has a lifetime prevalence of about 0.3 % (roughly 1 in 300 people) <sup>[2]</sup>.
• Brief psychotic disorder and psychotic features of mood disorders are less common but together account for an additional 1–2 % of the population.

Symptoms

Psychosis presents with a spectrum of symptoms that can be grouped into three major categories: positive, negative, and cognitive. The presence, severity, and duration of each symptom vary widely.

Positive Symptoms (additions to normal experience)

• Hallucinations – sensory perceptions without external stimulus.
  • Auditory (hearing voices) is the most common.
  • Visual, tactile, olfactory, or gustatory hallucinations may also occur.
• Delusions – fixed false beliefs despite contrary evidence.
  • Paranoid (e.g., “people are spying on me”).
  • Grandiose (e.g., “I have special powers”).
  • Somatic (e.g., “my organs are rotting”).
• Thought disorder – disorganized thinking that may manifest as:
  • Loose associations (jumping from topic to topic).
  • Neologisms (invented words).
  • Word salad (incoherent speech).
• Disorganized behavior – unpredictable or inappropriate actions, motor agitation, or catatonia.

Negative Symptoms (loss of normal functions)

• Avolition – reduced motivation to initiate activities.
• Flat affect – diminished emotional expression.
• Anhedonia – decreased ability to experience pleasure.
• Alogia – reduced speech output.
• Social withdrawal.

Cognitive Symptoms

• Poor attention and concentration.
• Working memory deficits.
• Impaired executive function (planning, problem‑solving).

Symptoms must persist for at least **one month** (or less if treated promptly) and cause functional impairment to meet diagnostic criteria for most psychotic disorders <sup>[3]</sup>.

Causes and Risk Factors

Psychosis is typically **multifactorial**. No single cause explains every case.

Genetic Factors

• First‑degree relatives of individuals with schizophrenia have a 10‑fold increased risk <sup>[4]</sup>.
• Genome‑wide association studies (GWAS) have identified > 100 loci linked to psychotic disorders.

Neurobiological Factors

• Imbalance in dopamine pathways, especially hyperactivity in the mesolimbic system, is a core hypothesis.
• Glutamate dysfunction, inflammatory markers, and structural brain changes (e.g., reduced gray matter in prefrontal cortex) also contribute <sup>[5]</sup>.

Medical and Neurological Causes

• Brain injuries, tumors, or stroke.
• Neurodegenerative diseases (e.g., Parkinson’s, Alzheimer’s).
• Endocrine disorders (thyroid disease, Cushing’s).
• Infections (HIV, syphilis, COVID‑19) and autoimmune encephalitis (e.g., anti‑NMDA‑receptor encephalitis).

Substance‑Induced Psychosis

• Stimulants: cocaine, methamphetamine.
• Hallucinogens: LSD, PCP.
• Cannabis – high‑potency THC increases risk, especially in vulnerable teens <sup>[6]</sup>.
• Alcohol withdrawal (delirium tremens).

Psychosocial Stressors

• Childhood trauma, bullying, or chronic abuse.
• Severe psychosocial stress (e.g., loss of a loved one, refugee status).
• Urban living and social isolation have modest associations.

Risk Profile Summary

High‑Risk Category	Key Factors
Genetic predisposition	Family history, identified risk alleles
Substance use	Heavy cannabis, stimulants, chronic alcohol
Medical comorbidities	Neurological disease, autoimmune encephalitis
Psychosocial stress	Trauma, homelessness, extreme stressors

Diagnosis

Diagnosing psychosis requires a thorough clinical evaluation. There is no single laboratory test that confirms the condition, but investigations help rule out medical mimics.

Clinical Interview

• Structured or semi‑structured tools (e.g., SCID‑5, MINI) to assess symptom criteria.
• Collateral history from family or caregivers.
• Assessment of duration, severity, and functional impact.

Mental Status Examination (MSE)

• Observes appearance, behavior, speech, mood, thought content, perception, cognition, insight, and judgment.

Laboratory Tests

• Baseline blood work: CBC, electrolytes, liver/kidney function, thyroid panel, vitamin B12, folate.
• Drug screen (urine or blood) to detect illicit substances.
• If autoimmune encephalitis suspected: serum and CSF autoantibody panels.

Imaging

• Magnetic Resonance Imaging (MRI) – preferred to rule out structural lesions.
• Computed Tomography (CT) – used when MRI unavailable or urgent.

Other Specialized Tests

• Electroencephalogram (EEG) – helps identify seizures or non‑convulsive status epilepticus.
• Neuropsychological testing – characterizes cognitive deficits.

Diagnostic Criteria

Most clinicians rely on the DSM‑5 or ICD‑11 definitions. For example, the DSM‑5 requires ≥ 2 of the following for > 1 month (or less if treated): delusions, hallucinations, disorganized speech, grossly disorganized or catatonic behavior, and negative symptoms <sup>[3]</sup>.

Treatment Options

Effective management usually combines **pharmacologic therapy**, **psychosocial interventions**, and **lifestyle modifications**. Early treatment improves long‑term outcomes.

Medications

• Antipsychotics – first‑line for most psychotic disorders.
  • Second‑generation (atypical) agents: risperidone, olanzapine, quetiapine, aripiprazole, clozapine (reserved for treatment‑resistant cases).
  • First‑generation (typical) agents: haloperidol, fluphenazine – useful for acute agitation.
  • Common side effects: weight gain, metabolic syndrome, extrapyramidal symptoms (EPS), QT prolongation. Monitoring labs (lipid panel, fasting glucose) is recommended <sup>[7]</sup>.
• Adjunctive meds
  • Lamotrigine or mood stabilizers for psychosis associated with bipolar disorder.
  • Selective serotonin reuptake inhibitors (SSRIs) when depressive symptoms coexist.

Psychosocial & Psychological Interventions

• Cognitive‑Behavioral Therapy for Psychosis (CBTp) – helps patients challenge delusional thinking and cope with hallucinations.
• Family Psychoeducation – reduces relapse rates by improving communication and medication adherence.
• Supported Employment & Social Skills Training – promotes functional recovery.
• Assertive Community Treatment (ACT) – intensive, multidisciplinary outreach for high‑risk individuals.

Procedures & Acute Management

• Intramuscular (IM) or intravenous antipsychotics for severe agitation or danger to self/others (e.g., haloperidol + lorazepam).
• Electroconvulsive Therapy (ECT) – indicated for catatonia, severe medication‑resistant depression with psychotic features, or acute relapse when rapid response is needed.

Lifestyle & Self‑Care Strategies

• Regular physical activity (150 min/week) reduces metabolic side effects and improves mood.
• Balanced diet low in saturated fats and sugars; consider omega‑3 supplementation (evidence suggests modest benefit).
• Avoid nicotine, alcohol, and recreational drugs that can exacerbate symptoms.
• Sleep hygiene – aim for 7‑9 hours, consistent schedule.
• Stress‑reduction techniques: mindfulness, yoga, relaxation training.

Living with Psychosis

Recovery is a personal journey. The following tips can help maintain stability and improve quality of life.

Medication Adherence

• Set daily alarms or use pill‑organizers.
• Discuss side‑effects with your prescriber; dose adjustments or switching agents can help.

Routine & Structure

• Keep a consistent daily schedule (meals, meds, activities).
• Break tasks into small, manageable steps.

Social Support

• Maintain contact with trusted family or friends.
• Join peer‑support groups (e.g., NAMI, local community programs).

Safety Planning

• Identify early warning signs (e.g., increased paranoia, sleep loss) and a plan for contacting a clinician.
• Keep emergency numbers handy; consider a “buddy system” for moments of crisis.

Work & Education

• Disclose diagnosis only if comfortable; request reasonable accommodations (flexible hours, quiet workspace).
• Utilize vocational rehab services that specialize in mental‑health populations.

Physical Health Monitoring

• Annual metabolic screening (weight, BMI, fasting glucose, lipids).
• Vaccinations – influenza, COVID‑19, pneumococcal, as recommended.

Prevention

While one cannot prevent all cases of psychosis, the risk can be reduced through targeted strategies.

• Early Identification – programs like “Ultra‑High Risk (UHR)” clinics screen adolescents for prodromal symptoms and intervene early with psychotherapy and low‑dose medication.
• Substance‑Use Reduction – public health campaigns and counseling to limit high‑potency cannabis and stimulant use.
• Stress Management – teaching coping skills in schools, workplaces, and for trauma survivors.
• Maternal & Perinatal Care – adequate prenatal nutrition, infection control, and avoiding obstetric complications lower neurodevelopmental risk.
• Vaccination & Infection Control – preventing neurotropic infections (e.g., measles, COVID‑19) that can trigger psychosis.

Complications

If left untreated or poorly managed, psychosis can lead to severe short‑ and long‑term complications.

• Functional Decline – loss of employment, homelessness, social isolation.
• Self‑Harm or Suicide – up to 10 % of individuals with schizophrenia die by suicide; risk is highest during the first psychotic episode <sup>[8]</sup>.
• Physical Health Problems – metabolic syndrome, cardiovascular disease, diabetes (often medication‑related).
• Legal Issues – aggression, substance‑related offenses, or inability to comply with court‑ordered treatment.
• Medication Non‑Adherence – can precipitate relapse, leading to hospitalization.
• Catatonia – life‑threatening if untreated; may cause dehydration, malnutrition, or pulmonary embolism.

When to Seek Emergency Care

---

References

1. World Health Organization. Schizophrenia. 2022. https://www.who.int/news-room/fact-sheets/detail/schizophrenia
2. Mayo Clinic. Schizophrenia – Statistics. 2023. https://www.mayoclinic.org/diseases-conditions/schizophrenia
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed. (DSM‑5). 2013.
4. National Institute of Mental Health. Genetics of Schizophrenia. 2021. https://www.nimh.nih.gov/health/topics/schizophrenia
5. Insel TR, et al. The neurobiology of psychosis. Nat Rev Neurosci. 2020;21: 655‑667.
6. National Academies of Sciences, Engineering, and Medicine. The health effects of cannabis and cannabinoids. 2022.
7. Cleveland Clinic. Antipsychotic medications – side effects and monitoring. 2023.
8. Hawton K, et al. Suicide risk in schizophrenia. BMJ. 2021;372:n705.

```